Literature DB >> 17690060

Sydenham's chorea: a clinical follow-up of 65 patients.

Kaan Demiroren1, Haluk Yavuz, Lokman Cam, Bulent Oran, Sevim Karaaslan, Saadet Demiroren.   

Abstract

Sydenham's chorea, the neurological manifestation of rheumatic fever, is the most common acquired chorea of childhood. In this retrospective study, the authors aim to present the clinical and laboratory findings of 65 Sydenham's chorea patients, followed up in a clinic over less than 7 years. The mean age at the onset of the symptoms was 11.7 +/- 2.6 years (range, 6-17 years). Of the patients, 63% were female and 37% were male (male/female: 1.7/1). Chorea was generalized in 78.5% of the patients, right hemichorea in 12.3%, and left hemichorea 9.2%. There was a history of rheumatic fever in 30.8% of the patients. Echocardiographic study showed cardiac valve involvement in 70.5% of 61 patients. Brain magnetic resonance imaging, which was performed on only 18 patients, was evaluated as normal in all. Electroencephalography was also performed on only 18 patients and showed abnormal waves in 50% of them. Pimozide was mostly the first choice of drug therapy. Nevertheless, drug therapy was not needed in 18.5% of the patients. The recovery period of the first attack of the chorea was 1 to 6 months in 51.7% of the patients. The recurrence rate was 37.9%. In conclusion, Sydenham's chorea is still an important health problem in Turkey with respect to its morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690060     DOI: 10.1177/0883073807302614

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  21 in total

1.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Authors:  Lior Brimberg; Itai Benhar; Adita Mascaro-Blanco; Kathy Alvarez; Dafna Lotan; Christine Winter; Julia Klein; Allon E Moses; Finn E Somnier; James F Leckman; Susan E Swedo; Madeleine W Cunningham; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

2.  Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Authors:  Dafna Lotan; Itai Benhar; Kathy Alvarez; Adita Mascaro-Blanco; Lior Brimberg; Dan Frenkel; Madeleine W Cunningham; Daphna Joel
Journal:  Brain Behav Immun       Date:  2014-02-20       Impact factor: 7.217

3.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

4.  Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS).

Authors:  Jill Leon; Rebecca Hommer; Paul Grant; Cristan Farmer; Precilla D'Souza; Riley Kessler; Kyle Williams; James F Leckman; Susan Swedo
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-11-08       Impact factor: 4.785

Review 5.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

Review 6.  Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond.

Authors:  M W Cunningham; C J Cox
Journal:  Acta Physiol (Oxf)       Date:  2015-11-05       Impact factor: 6.311

7.  Successful treatment of Sydenham's chorea with intravenous immunoglobulin.

Authors:  Nienke Anne Boersma; Herman Schippers; Taco Kuijpers; Jojanneke Heidema
Journal:  BMJ Case Rep       Date:  2016-02-01

Review 8.  Brain-reactive antibodies and disease.

Authors:  B Diamond; G Honig; S Mader; L Brimberg; B T Volpe
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

9.  Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease.

Authors:  Carol J Cox; Meenakshi Sharma; James F Leckman; Jonathan Zuccolo; Amir Zuccolo; Abraham Kovoor; Susan E Swedo; Madeleine W Cunningham
Journal:  J Immunol       Date:  2013-11-01       Impact factor: 5.422

Review 10.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.